KHCM
ADAP

Kettle Hill Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Kettle Hill Capital Management’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-261,411
Closed -$382K – 55
2022
Q4 		$382K Buy
261,411
+8,277
+3% +$12.1K 0.08% 44
2022
Q3 		$272K Buy
+253,134
New +$272K 0.06% 63